Net position, by region
One dot per nation. The bar marks each region’s mean. Filled dots are net gains; hollow dots are net losses.
Readiness against outcome
Each nation’s readiness to take the gain against its net position. Nations below the zero line lose more than they capture.
Mean net position by region
Loss exposure in this scenario: pension and long-term care liabilities in ageing populations.
All 197 nations
Capture is gain exposure times readiness. Loss is loss exposure times what adaptability does not cover. The binding capability is the weakest of those the scenario requires: raising it raises the capture rate most.
| Binding capability | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | North America | Gainer | +29.8 | 44.4 | 14.6 | 77 | 78 | Population Health 14 · Established |
| 2 | South Africa | Africa | Gainer | +27.7 | 43.3 | 15.6 | 51 | 55 | Population Health 9.3 · Transitional |
| 4 | Australia | Indo-Pacific | Gainer | +26.2 | 37.8 | 11.6 | 79 | 82 | Biotechnology & Health Technologies 15.2 · Advanced |
| 3 | Canada | North America | Gainer | +26.2 | 40.5 | 14.3 | 81 | 80 | Biotechnology & Health Technologies 15.8 · Advanced |
| 5 | Germany | Europe | Gainer | +24.7 | 37.4 | 12.8 | 82 | 85 | Population Health 15.7 · Advanced |
| 6 | United Arab Emirates | Gulf and Middle East | Gainer | +24.6 | 25.9 | 1.3 | 52 | 64 | Biotechnology & Health Technologies 8 · Foundational |
| 7 | Netherlands | Europe | Gainer | +24.2 | 36.5 | 12.3 | 84 | 84 | Biotechnology & Health Technologies 16.6 · Advanced |
| 8 | Sweden | Europe | Gainer | +24.1 | 34.0 | 10.0 | 81 | 87 | Biotechnology & Health Technologies 15.6 · Advanced |
| 9 | Denmark | Europe | Gainer | +23.2 | 32.9 | 9.8 | 79 | 87 | Biotechnology & Health Technologies 15 · Advanced |
| 10 | United Kingdom | Europe | Gainer | +22.3 | 38.2 | 15.9 | 82 | 80 | Population Health 16 · Advanced |
| 11 | Finland | Europe | Gainer | +20.8 | 32.9 | 12.1 | 74 | 85 | Biotechnology & Health Technologies 13 · Established |
| 12 | Norway | Europe | Gainer | +20.5 | 31.5 | 11.0 | 70 | 85 | Biotechnology & Health Technologies 12 · Established |
| 13 | France | Europe | Gainer | +19.7 | 36.1 | 16.3 | 83 | 80 | Population Health 16.3 · Advanced |
| 15 | Rwanda | Africa | Gainer | +18.8 | 23.4 | 4.5 | 31 | 41 | Biotechnology & Health Technologies 4.2 · Nascent |
| 14 | Switzerland | Europe | Gainer | +18.8 | 31.0 | 12.2 | 82 | 84 | Regulatory Governance & Strategic Controls 16 · Advanced |
| 16 | Saudi Arabia | Gulf and Middle East | Gainer | +18.7 | 27.9 | 9.2 | 49 | 59 | Biotechnology & Health Technologies 8 · Foundational |
| 17 | India | South Asia | Gainer | +18.6 | 33.9 | 15.3 | 49 | 53 | Population Health 8.3 · Foundational |
| 18 | Israel | Gulf and Middle East | Gainer | +18.3 | 31.8 | 13.5 | 75 | 72 | Social Infrastructure 14.8 · Established |
| 19 | New Zealand | Indo-Pacific | Gainer | +17.8 | 31.2 | 13.5 | 63 | 79 | Biotechnology & Health Technologies 10.2 · Transitional |
| 20 | Qatar | Gulf and Middle East | Gainer | +17.5 | 19.0 | 1.4 | 38 | 55 | Biotechnology & Health Technologies 4.4 · Nascent |
| 21 | Uganda | Africa | Gainer | +17.1 | 18.8 | 1.7 | 26 | 33 | Biotechnology & Health Technologies 4 · Nascent |
| 22 | Kenya | Africa | Gainer | +16.8 | 23.5 | 6.7 | 32 | 40 | Biotechnology & Health Technologies 5.2 · Nascent |
| 23 | Singapore | Indo-Pacific | Gainer | +16.7 | 24.0 | 7.3 | 78 | 87 | Biotechnology & Health Technologies 14.4 · Established |
| 24 | Nigeria | Africa | Gainer | +15.7 | 23.1 | 7.3 | 28 | 35 | Population Health 4.3 · Nascent |
| 25 | Türkiye | Gulf and Middle East | Gainer | +14.9 | 32.8 | 17.9 | 57 | 59 | Biotechnology & Health Technologies 10.4 · Transitional |
| 26 | Belgium | Europe | Gainer | +14.7 | 32.9 | 18.2 | 74 | 76 | Regulatory Governance & Strategic Controls 14.3 · Established |
| 27 | Senegal | Africa | Gainer | +14.5 | 21.7 | 7.1 | 29 | 37 | Biotechnology & Health Technologies 4.6 · Nascent |
| 28 | Mexico | Latin America and Caribbean | Gainer | +14.4 | 33.3 | 18.9 | 52 | 55 | Biotechnology & Health Technologies 9.8 · Transitional |
| 30 | Austria | Europe | Gainer | +13.2 | 29.0 | 15.8 | 70 | 80 | Biotechnology & Health Technologies 12.8 · Established |
| 29 | Taiwan | Indo-Pacific | Gainer | +13.2 | 30.7 | 17.5 | 71 | 74 | Biotechnology & Health Technologies 13.2 · Established |
| 32 | Ireland | Europe | Gainer | +12.7 | 30.3 | 17.6 | 63 | 74 | Biotechnology & Health Technologies 11 · Transitional |
| 31 | South Korea | Indo-Pacific | Gainer | +12.7 | 25.5 | 12.8 | 81 | 81 | Population Health 16 · Advanced |
| 33 | Zambia | Africa | Gainer | +12.2 | 15.9 | 3.7 | 20 | 31 | Biotechnology & Health Technologies 2.4 · Inception |
| 34 | Côte d'Ivoire | Africa | Gainer | +11.3 | 16.0 | 4.7 | 19 | 33 | Biotechnology & Health Technologies 2.2 · Inception |
| 35 | Morocco | Africa | Gainer | +11.0 | 30.9 | 19.9 | 39 | 49 | Biotechnology & Health Technologies 6.4 · Foundational |
| 36 | Ghana | Africa | Gainer | +10.9 | 23.7 | 12.8 | 31 | 40 | Biotechnology & Health Technologies 4.8 · Nascent |
| 38 | Tanzania | Africa | Gainer | +10.6 | 18.0 | 7.4 | 25 | 35 | Biotechnology & Health Technologies 3.4 · Nascent |
| 37 | Egypt | Gulf and Middle East | Gainer | +10.6 | 26.8 | 16.2 | 42 | 43 | Regulatory Governance & Strategic Controls 7.7 · Foundational |
| 40 | Ethiopia | Africa | Gainer | +10.2 | 18.0 | 7.9 | 24 | 30 | Biotechnology & Health Technologies 3.6 · Nascent |
| 39 | Namibia | Africa | Gainer | +10.2 | 18.7 | 8.5 | 23 | 43 | Biotechnology & Health Technologies 2 · Inception |
| 41 | Brazil | Latin America and Caribbean | Gainer | +10.1 | 30.2 | 20.1 | 57 | 59 | Regulatory Governance & Strategic Controls 10.7 · Transitional |
| 42 | Japan | Indo-Pacific | Gainer | +10.0 | 24.4 | 14.3 | 83 | 82 | Regulatory Governance & Strategic Controls 16.3 · Advanced |
| 43 | Angola | Africa | Mixed | +9.8 | 11.7 | 1.9 | 14 | 27 | Biotechnology & Health Technologies 1.2 · Inception |
| 44 | Malaysia | Indo-Pacific | Mixed | +9.6 | 27.1 | 17.6 | 53 | 62 | Biotechnology & Health Technologies 9.4 · Transitional |
| 46 | Benin | Africa | Mixed | +9.4 | 12.0 | 2.6 | 15 | 29 | Biotechnology & Health Technologies 1 · Inception |
| 45 | Mozambique | Africa | Mixed | +9.4 | 14.2 | 4.8 | 17 | 25 | Biotechnology & Health Technologies 2.2 · Inception |
| 47 | Spain | Europe | Mixed | +9.3 | 32.2 | 22.9 | 72 | 70 | Biotechnology & Health Technologies 13.6 · Established |
| 48 | Sierra Leone | Africa | Mixed | +9.1 | 11.9 | 2.8 | 14 | 24 | Biotechnology & Health Technologies 1.2 · Inception |
| 49 | Poland | Europe | Mixed | +8.7 | 33.9 | 25.2 | 60 | 66 | Biotechnology & Health Technologies 11.2 · Transitional |
| 50 | Jordan | Gulf and Middle East | Mixed | +8.3 | 19.6 | 11.3 | 33 | 43 | Biotechnology & Health Technologies 4.4 · Nascent |
| 51 | Oman | Gulf and Middle East | Mixed | +7.6 | 16.7 | 9.1 | 31 | 50 | Biotechnology & Health Technologies 2.8 · Inception |
| 52 | Cameroon | Africa | Mixed | +7.4 | 14.1 | 6.7 | 17 | 27 | Biotechnology & Health Technologies 2.2 · Inception |
| 53 | Kuwait | Gulf and Middle East | Mixed | +7.3 | 15.6 | 8.3 | 30 | 44 | Biotechnology & Health Technologies 3 · Nascent |
| 54 | DR Congo | Africa | Mixed | +6.5 | 9.6 | 3.1 | 12 | 16 | Biotechnology & Health Technologies 1.6 · Inception |
| 55 | Estonia | Europe | Mixed | +5.8 | 25.9 | 20.1 | 52 | 75 | Biotechnology & Health Technologies 7.4 · Foundational |
| 56 | Pakistan | South Asia | Mixed | +5.7 | 22.2 | 16.6 | 32 | 34 | Population Health 5.3 · Nascent |
| 58 | Niger | Africa | Mixed | +5.5 | 9.4 | 3.9 | 12 | 20 | Biotechnology & Health Technologies 1.2 · Inception |
| 57 | Russia | Russia and Eurasia | Mixed | +5.5 | 35.0 | 29.5 | 55 | 56 | Population Health 10 · Transitional |
| 59 | Czechia | Europe | Mixed | +5.4 | 30.8 | 25.4 | 57 | 66 | Biotechnology & Health Technologies 9.8 · Transitional |
| 60 | Zimbabwe | Africa | Mixed | +5.1 | 16.1 | 11.0 | 20 | 26 | Biotechnology & Health Technologies 2.6 · Inception |
| 61 | China | China | Mixed | +5.0 | 26.7 | 21.7 | 65 | 66 | Population Health 11.7 · Transitional |
| 62 | Mali | Africa | Mixed | +4.9 | 11.0 | 6.1 | 14 | 22 | Biotechnology & Health Technologies 1.6 · Inception |
| 63 | Lithuania | Europe | Mixed | +4.6 | 31.4 | 26.8 | 51 | 67 | Biotechnology & Health Technologies 8 · Foundational |
| 64 | Philippines | Indo-Pacific | Mixed | +4.4 | 22.0 | 17.6 | 37 | 49 | Biotechnology & Health Technologies 6 · Foundational |
| 66 | Burkina Faso | Africa | Mixed | +4.0 | 11.1 | 7.1 | 14 | 23 | Biotechnology & Health Technologies 1.6 · Inception |
| 65 | Indonesia | Indo-Pacific | Mixed | +4.0 | 25.5 | 21.5 | 46 | 52 | Biotechnology & Health Technologies 8.6 · Foundational |
| 67 | Botswana | Africa | Mixed | +3.9 | 19.7 | 15.9 | 24 | 46 | Biotechnology & Health Technologies 1.8 · Inception |
| 68 | Hungary | Europe | Mixed | +3.5 | 34.4 | 30.9 | 55 | 61 | Biotechnology & Health Technologies 10 · Transitional |
| 70 | Palestine | Gulf and Middle East | Mixed | +3.2 | 8.9 | 5.7 | 16 | 27 | Biotechnology & Health Technologies 1.4 · Inception |
| 69 | Tunisia | Africa | Mixed | +3.2 | 26.9 | 23.7 | 39 | 46 | Biotechnology & Health Technologies 6 · Foundational |
| 73 | Bahrain | Gulf and Middle East | Mixed | +2.9 | 13.5 | 10.6 | 28 | 50 | Biotechnology & Health Technologies 2 · Inception |
| 72 | Peru | Latin America and Caribbean | Mixed | +2.9 | 23.9 | 21.0 | 37 | 49 | Biotechnology & Health Technologies 5.6 · Nascent |
| 71 | Chile | Latin America and Caribbean | Mixed | +2.9 | 22.3 | 19.4 | 46 | 64 | Biotechnology & Health Technologies 6.6 · Foundational |
| 74 | Iran | Gulf and Middle East | Mixed | +2.6 | 23.9 | 21.3 | 41 | 38 | Regulatory Governance & Strategic Controls 6.7 · Foundational |
| 75 | Chad | Africa | Mixed | +2.4 | 5.5 | 3.1 | 7 | 15 | Biotechnology & Health Technologies 0.2 · Inception |
| 77 | São Tomé & Príncipe | Africa | Mixed | +2.2 | 9.1 | 6.9 | 12 | 25 | Biotechnology & Health Technologies 0.2 · Inception |
| 76 | Mauritius | Africa | Mixed | +2.2 | 23.0 | 20.8 | 35 | 58 | Biotechnology & Health Technologies 3.8 · Nascent |
| 79 | Liberia | Africa | Mixed | +2.1 | 9.4 | 7.3 | 11 | 21 | Biotechnology & Health Technologies 0.8 · Inception |
| 78 | Algeria | Africa | Mixed | +2.1 | 21.5 | 19.4 | 31 | 39 | Biotechnology & Health Technologies 4.4 · Nascent |
| 80 | Iraq | Gulf and Middle East | Mixed | +1.9 | 12.7 | 10.8 | 20 | 27 | Biotechnology & Health Technologies 2.2 · Inception |
| 81 | Luxembourg | Europe | Mixed | +1.4 | 19.3 | 17.9 | 45 | 74 | Biotechnology & Health Technologies 5 · Nascent |
| 83 | Gambia | Africa | Mixed | +0.9 | 11.5 | 10.6 | 15 | 23 | Biotechnology & Health Technologies 1.6 · Inception |
| 82 | Iceland | Europe | Mixed | +0.9 | 19.5 | 18.6 | 48 | 73 | Biotechnology & Health Technologies 6 · Foundational |
| 84 | Madagascar | Africa | Mixed | +0.6 | 11.9 | 11.2 | 16 | 24 | Biotechnology & Health Technologies 2 · Inception |
| 85 | Malawi | Africa | Mixed | +0.4 | 11.8 | 11.4 | 18 | 24 | Biotechnology & Health Technologies 2.2 · Inception |
| 86 | Eswatini | Africa | Mixed | +0.3 | 12.5 | 12.2 | 15 | 27 | Biotechnology & Health Technologies 1 · Inception |
| 88 | Sudan | Africa | Mixed | 0.0 | 7.9 | 7.9 | 10 | 14 | Biotechnology & Health Technologies 1.2 · Inception |
| 87 | Vietnam | Indo-Pacific | Mixed | 0.0 | 21.5 | 21.5 | 47 | 53 | Biotechnology & Health Technologies 8.2 · Foundational |
| 89 | Argentina | Latin America and Caribbean | Mixed | −0.3 | 25.4 | 25.7 | 50 | 51 | Regulatory Governance & Strategic Controls 8.7 · Foundational |
| 90 | Colombia | Latin America and Caribbean | Mixed | −0.5 | 23.3 | 23.8 | 41 | 53 | Biotechnology & Health Technologies 6.2 · Foundational |
| 91 | South Sudan | Africa | Mixed | −0.6 | 3.5 | 4.1 | 4 | 8 | Biotechnology & Health Technologies 0 · Inception |
| 92 | Guinea-Bissau | Africa | Mixed | −0.7 | 5.9 | 6.6 | 7 | 15 | Biotechnology & Health Technologies 0.2 · Inception |
| 93 | Portugal | Europe | Mixed | −0.8 | 25.3 | 26.1 | 57 | 68 | Biotechnology & Health Technologies 9.6 · Transitional |
| 94 | Somalia | Africa | Mixed | −1.5 | 3.5 | 5.0 | 4 | 9 | Biotechnology & Health Technologies 0 · Inception |
| 95 | Thailand | Indo-Pacific | Mixed | −2.1 | 23.3 | 25.5 | 52 | 57 | Biotechnology & Health Technologies 9 · Transitional |
| 96 | Gabon | Africa | Mixed | −2.5 | 12.0 | 14.5 | 16 | 26 | Biotechnology & Health Technologies 1.4 · Inception |
| 97 | Afghanistan | South Asia | Mixed | −2.6 | 4.5 | 7.1 | 6 | 10 | Biotechnology & Health Technologies 0 · Inception |
| 98 | Uruguay | Latin America and Caribbean | Mixed | −2.8 | 20.0 | 22.8 | 40 | 61 | Biotechnology & Health Technologies 5 · Nascent |
| 99 | Italy | Europe | Mixed | −3.1 | 27.7 | 30.8 | 69 | 63 | Regulatory Governance & Strategic Controls 13.3 · Established |
| 100 | Burundi | Africa | Mixed | −3.3 | 6.1 | 9.3 | 8 | 17 | Biotechnology & Health Technologies 0.2 · Inception |
| 101 | Guinea | Africa | Mixed | −3.4 | 9.9 | 13.3 | 13 | 20 | Biotechnology & Health Technologies 1.2 · Inception |
| 102 | Slovakia | Europe | Mixed | −3.8 | 23.5 | 27.3 | 45 | 62 | Biotechnology & Health Technologies 6.6 · Foundational |
| 103 | Kazakhstan | Russia and Eurasia | Mixed | −3.9 | 22.5 | 26.4 | 38 | 50 | Biotechnology & Health Technologies 5.8 · Nascent |
| 105 | Togo | Africa | Mixed | −4.3 | 10.1 | 14.3 | 14 | 27 | Biotechnology & Health Technologies 1 · Inception |
| 104 | Latvia | Europe | Mixed | −4.3 | 24.9 | 29.2 | 43 | 64 | Biotechnology & Health Technologies 5.6 · Nascent |
| 106 | Slovenia | Europe | Mixed | −5.1 | 22.3 | 27.4 | 53 | 67 | Biotechnology & Health Technologies 8.4 · Foundational |
| 107 | Mongolia | Indo-Pacific | Mixed | −5.5 | 15.7 | 21.1 | 24 | 41 | Biotechnology & Health Technologies 2.2 · Inception |
| 108 | Bangladesh | South Asia | Mixed | −5.7 | 18.4 | 24.1 | 33 | 36 | Biotechnology & Health Technologies 5.6 · Nascent |
| 110 | Mauritania | Africa | Mixed | −5.9 | 10.5 | 16.4 | 13 | 22 | Biotechnology & Health Technologies 1.2 · Inception |
| 109 | Dominican Republic | Latin America and Caribbean | Mixed | −5.9 | 16.6 | 22.5 | 25 | 44 | Biotechnology & Health Technologies 2.4 · Inception |
| 111 | Djibouti | Africa | Mixed | −6.4 | 8.1 | 14.5 | 10 | 21 | Biotechnology & Health Technologies 0.2 · Inception |
| 113 | Cabo Verde | Africa | Mixed | −6.5 | 12.3 | 18.8 | 18 | 38 | Biotechnology & Health Technologies 0.4 · Inception |
| 112 | Costa Rica | Latin America and Caribbean | Mixed | −6.5 | 17.1 | 23.6 | 37 | 53 | Biotechnology & Health Technologies 4.2 · Nascent |
| 114 | Central African Rep. | Africa | Mixed | −6.6 | 4.7 | 11.3 | 6 | 12 | Biotechnology & Health Technologies 0.2 · Inception |
| 115 | Guatemala | Latin America and Caribbean | Mixed | −7.3 | 12.5 | 19.8 | 21 | 34 | Biotechnology & Health Technologies 2.2 · Inception |
| 116 | Congo | Africa | Mixed | −7.6 | 8.0 | 15.6 | 11 | 21 | Biotechnology & Health Technologies 0.8 · Inception |
| 117 | Lesotho | Africa | Mixed | −7.9 | 11.0 | 18.9 | 13 | 26 | Biotechnology & Health Technologies 0.8 · Inception |
| 118 | Eritrea | Africa | Mixed | −8.2 | 6.4 | 14.6 | 9 | 13 | Biotechnology & Health Technologies 0.6 · Inception |
| 120 | Yemen | Gulf and Middle East | Mixed | −8.4 | 3.3 | 11.7 | 5 | 9 | Biotechnology & Health Technologies 0.2 · Inception |
| 119 | Ukraine | Russia and Eurasia | Mixed | −8.4 | 28.0 | 36.4 | 42 | 49 | Biotechnology & Health Technologies 7 · Foundational |
| 121 | Tajikistan | Russia and Eurasia | Mixed | −8.5 | 9.6 | 18.1 | 16 | 29 | Biotechnology & Health Technologies 1.2 · Inception |
| 122 | Serbia | Europe | Mixed | −9.0 | 25.7 | 34.7 | 44 | 53 | Biotechnology & Health Technologies 6.8 · Foundational |
| 123 | Libya | Africa | Mixed | −9.1 | 9.6 | 18.8 | 14 | 17 | Biotechnology & Health Technologies 1.4 · Inception |
| 125 | Maldives | South Asia | Mixed | −9.3 | 10.5 | 19.8 | 20 | 36 | Biotechnology & Health Technologies 1 · Inception |
| 124 | Seychelles | Africa | Mixed | −9.3 | 13.9 | 23.2 | 22 | 46 | Biotechnology & Health Technologies 0.8 · Inception |
| 126 | Cyprus | Europe | Mixed | −9.5 | 17.1 | 26.6 | 36 | 59 | Biotechnology & Health Technologies 3.8 · Nascent |
| 127 | Nepal | South Asia | Mixed | −9.6 | 12.3 | 21.9 | 20 | 31 | Biotechnology & Health Technologies 2 · Inception |
| 128 | Romania | Europe | Mixed | −9.7 | 26.5 | 36.2 | 48 | 56 | Biotechnology & Health Technologies 8.4 · Foundational |
| 129 | Papua New Guinea | Indo-Pacific | Mixed | −9.9 | 8.9 | 18.9 | 13 | 22 | Biotechnology & Health Technologies 1.2 · Inception |
| 131 | Honduras | Latin America and Caribbean | Loser | −10.4 | 11.4 | 21.8 | 19 | 31 | Biotechnology & Health Technologies 1.8 · Inception |
| 130 | Ecuador | Latin America and Caribbean | Loser | −10.4 | 16.2 | 26.6 | 30 | 42 | Biotechnology & Health Technologies 3.8 · Nascent |
| 132 | Bulgaria | Europe | Loser | −11.2 | 25.3 | 36.4 | 42 | 53 | Biotechnology & Health Technologies 6.6 · Foundational |
| 133 | Panama | Latin America and Caribbean | Loser | −11.3 | 13.8 | 25.1 | 30 | 48 | Biotechnology & Health Technologies 3.2 · Nascent |
| 134 | Sri Lanka | South Asia | Loser | −11.4 | 17.0 | 28.3 | 33 | 42 | Biotechnology & Health Technologies 4.2 · Nascent |
| 136 | Uzbekistan | Russia and Eurasia | Loser | −11.6 | 13.7 | 25.3 | 28 | 39 | Biotechnology & Health Technologies 3.8 · Nascent |
| 135 | Malta | Europe | Loser | −11.6 | 18.7 | 30.3 | 40 | 63 | Biotechnology & Health Technologies 4.4 · Nascent |
| 137 | Belize | Latin America and Caribbean | Loser | −11.7 | 9.1 | 20.8 | 15 | 33 | Biotechnology & Health Technologies 0.2 · Inception |
| 138 | Equatorial Guinea | Africa | Loser | −11.9 | 7.4 | 19.4 | 9 | 19 | Biotechnology & Health Technologies 0.4 · Inception |
| 139 | Bhutan | South Asia | Loser | −12.0 | 9.6 | 21.6 | 16 | 33 | Biotechnology & Health Technologies 0.2 · Inception |
| 140 | Croatia | Europe | Loser | −12.1 | 22.6 | 34.6 | 41 | 58 | Biotechnology & Health Technologies 5.6 · Nascent |
| 143 | Syria | Gulf and Middle East | Loser | −12.2 | 5.4 | 17.6 | 9 | 11 | Biotechnology & Health Technologies 0.8 · Inception |
| 142 | Comoros | Africa | Loser | −12.2 | 6.5 | 18.6 | 8 | 18 | Biotechnology & Health Technologies 0.2 · Inception |
| 141 | Cambodia | Indo-Pacific | Loser | −12.2 | 9.7 | 21.9 | 17 | 32 | Biotechnology & Health Technologies 1.4 · Inception |
| 144 | Nicaragua | Latin America and Caribbean | Loser | −12.6 | 10.5 | 23.1 | 18 | 31 | Biotechnology & Health Technologies 1.4 · Inception |
| 145 | Greece | Europe | Loser | −12.8 | 23.0 | 35.7 | 47 | 57 | Biotechnology & Health Technologies 7.4 · Foundational |
| 147 | Brunei | Indo-Pacific | Loser | −13.7 | 9.9 | 23.7 | 22 | 44 | Biotechnology & Health Technologies 0.6 · Inception |
| 146 | Jamaica | Latin America and Caribbean | Loser | −13.7 | 14.1 | 27.8 | 25 | 43 | Biotechnology & Health Technologies 2.6 · Inception |
| 148 | Bolivia | Latin America and Caribbean | Loser | −13.8 | 11.1 | 24.9 | 19 | 34 | Biotechnology & Health Technologies 1.2 · Inception |
| 149 | Georgia | Russia and Eurasia | Loser | −14.1 | 18.9 | 33.0 | 31 | 50 | Biotechnology & Health Technologies 3.4 · Nascent |
| 150 | El Salvador | Latin America and Caribbean | Loser | −14.2 | 13.0 | 27.2 | 23 | 38 | Biotechnology & Health Technologies 2 · Inception |
| 151 | Haiti | Latin America and Caribbean | Loser | −14.5 | 5.4 | 19.9 | 8 | 13 | Biotechnology & Health Technologies 0.6 · Inception |
| 152 | Laos | Indo-Pacific | Loser | −14.7 | 8.5 | 23.2 | 14 | 24 | Biotechnology & Health Technologies 1 · Inception |
| 153 | Belarus | Russia and Eurasia | Loser | −15.1 | 21.4 | 36.5 | 36 | 46 | Biotechnology & Health Technologies 5.2 · Nascent |
| 154 | Bahamas | Latin America and Caribbean | Loser | −15.9 | 10.6 | 26.5 | 19 | 40 | Biotechnology & Health Technologies 0.2 · Inception |
| 156 | Trinidad & Tobago | Latin America and Caribbean | Loser | −16.2 | 12.9 | 29.0 | 27 | 47 | Biotechnology & Health Technologies 2.2 · Inception |
| 155 | Azerbaijan | Russia and Eurasia | Loser | −16.2 | 13.1 | 29.3 | 25 | 43 | Biotechnology & Health Technologies 2.4 · Inception |
| 157 | Suriname | Latin America and Caribbean | Loser | −16.5 | 10.7 | 27.1 | 16 | 31 | Biotechnology & Health Technologies 0.6 · Inception |
| 158 | Nauru | Indo-Pacific | Loser | −16.8 | 6.8 | 23.6 | 9 | 18 | Biotechnology & Health Technologies 0 · Inception |
| 160 | Timor-Leste | Indo-Pacific | Loser | −17.1 | 5.7 | 22.8 | 10 | 23 | Biotechnology & Health Technologies 0 · Inception |
| 159 | Liechtenstein | Europe | Loser | −17.1 | 11.4 | 28.5 | 29 | 63 | Biotechnology & Health Technologies 1.4 · Inception |
| 161 | Kyrgyzstan | Russia and Eurasia | Loser | −17.2 | 11.1 | 28.3 | 20 | 33 | Biotechnology & Health Technologies 1.6 · Inception |
| 162 | Vanuatu | Indo-Pacific | Loser | −17.7 | 6.8 | 24.5 | 11 | 22 | Biotechnology & Health Technologies 0.2 · Inception |
| 163 | Moldova | Russia and Eurasia | Loser | −18.1 | 17.5 | 35.6 | 28 | 43 | Biotechnology & Health Technologies 3 · Nascent |
| 165 | Fiji | Indo-Pacific | Loser | −18.3 | 12.5 | 30.8 | 19 | 36 | Biotechnology & Health Technologies 1 · Inception |
| 164 | Paraguay | Latin America and Caribbean | Loser | −18.3 | 9.8 | 28.1 | 22 | 39 | Biotechnology & Health Technologies 1.8 · Inception |
| 166 | Guyana | Latin America and Caribbean | Loser | −18.4 | 10.1 | 28.5 | 17 | 32 | Biotechnology & Health Technologies 1 · Inception |
| 167 | Cuba | Latin America and Caribbean | Loser | −19.1 | 18.7 | 37.9 | 41 | 38 | Regulatory Governance & Strategic Controls 6 · Foundational |
| 168 | Solomon Islands | Indo-Pacific | Loser | −19.3 | 5.9 | 25.2 | 11 | 22 | Biotechnology & Health Technologies 0.2 · Inception |
| 169 | Kiribati | Indo-Pacific | Loser | −19.5 | 7.2 | 26.7 | 9 | 19 | Biotechnology & Health Technologies 0 · Inception |
| 170 | Lebanon | Gulf and Middle East | Loser | −20.8 | 12.4 | 33.2 | 24 | 24 | Biotechnology & Health Technologies 3.6 · Nascent |
| 171 | Samoa | Indo-Pacific | Loser | −21.2 | 8.8 | 30.0 | 13 | 27 | Biotechnology & Health Technologies 0.2 · Inception |
| 172 | North Macedonia | Europe | Loser | −21.4 | 14.5 | 35.9 | 27 | 46 | Biotechnology & Health Technologies 2.4 · Inception |
| 173 | Barbados | Latin America and Caribbean | Loser | −21.7 | 10.4 | 32.0 | 22 | 46 | Biotechnology & Health Technologies 0.8 · Inception |
| 175 | Venezuela | Latin America and Caribbean | Loser | −22.2 | 13.4 | 35.6 | 22 | 22 | Biotechnology & Health Technologies 3.4 · Nascent |
| 174 | Armenia | Russia and Eurasia | Loser | −22.2 | 13.2 | 35.5 | 27 | 44 | Biotechnology & Health Technologies 2.8 · Inception |
| 176 | Marshall Islands | Indo-Pacific | Loser | −22.7 | 6.3 | 29.0 | 9 | 18 | Biotechnology & Health Technologies 0 · Inception |
| 177 | Micronesia | Indo-Pacific | Loser | −22.8 | 6.2 | 29.1 | 9 | 18 | Biotechnology & Health Technologies 0 · Inception |
| 178 | Kosovo | Europe | Loser | −23.0 | 12.1 | 35.1 | 18 | 33 | Biotechnology & Health Technologies 1.2 · Inception |
| 179 | Tonga | Indo-Pacific | Loser | −23.6 | 7.7 | 31.3 | 13 | 25 | Biotechnology & Health Technologies 0.2 · Inception |
| 180 | Myanmar | Indo-Pacific | Loser | −23.7 | 9.5 | 33.2 | 16 | 19 | Biotechnology & Health Technologies 2.2 · Inception |
| 181 | Antigua & Barbuda | Latin America and Caribbean | Loser | −24.3 | 7.3 | 31.6 | 17 | 36 | Biotechnology & Health Technologies 0.2 · Inception |
| 182 | Turkmenistan | Russia and Eurasia | Loser | −24.5 | 8.1 | 32.6 | 14 | 23 | Biotechnology & Health Technologies 0.6 · Inception |
| 183 | Montenegro | Europe | Loser | −24.8 | 13.9 | 38.7 | 26 | 45 | Biotechnology & Health Technologies 2 · Inception |
| 184 | Andorra | Europe | Loser | −25.8 | 10.8 | 36.5 | 24 | 51 | Biotechnology & Health Technologies 0.2 · Inception |
| 185 | Albania | Europe | Loser | −26.7 | 10.6 | 37.3 | 22 | 43 | Biotechnology & Health Technologies 1.2 · Inception |
| 186 | Grenada | Latin America and Caribbean | Loser | −27.6 | 8.0 | 35.6 | 16 | 32 | Biotechnology & Health Technologies 0.4 · Inception |
| 187 | Tuvalu | Indo-Pacific | Loser | −28.1 | 7.2 | 35.3 | 9 | 19 | Biotechnology & Health Technologies 0 · Inception |
| 188 | Dominica | Latin America and Caribbean | Loser | −28.2 | 7.9 | 36.1 | 15 | 33 | Biotechnology & Health Technologies 0.2 · Inception |
| 190 | Saint Kitts & Nevis | Latin America and Caribbean | Loser | −28.3 | 7.5 | 35.7 | 15 | 31 | Biotechnology & Health Technologies 0.4 · Inception |
| 189 | Monaco | Europe | Loser | −28.3 | 9.9 | 38.2 | 28 | 55 | Biotechnology & Health Technologies 1.2 · Inception |
| 191 | Saint Vincent & Grenadines | Latin America and Caribbean | Loser | −29.0 | 7.8 | 36.8 | 15 | 31 | Biotechnology & Health Technologies 0.4 · Inception |
| 192 | San Marino | Europe | Loser | −30.6 | 8.2 | 38.8 | 23 | 51 | Biotechnology & Health Technologies 0 · Inception |
| 193 | Saint Lucia | Latin America and Caribbean | Loser | −33.0 | 6.4 | 39.4 | 15 | 31 | Biotechnology & Health Technologies 0.4 · Inception |
| 194 | Palau | Indo-Pacific | Loser | −33.4 | 7.8 | 41.2 | 12 | 23 | Biotechnology & Health Technologies 0 · Inception |
| 195 | North Korea | Indo-Pacific | Loser | −33.8 | 10.3 | 44.1 | 19 | 18 | Regulatory Governance & Strategic Controls 2.7 · Inception |
| 196 | Bosnia & Herzegovina | Europe | Loser | −33.9 | 11.0 | 44.9 | 24 | 38 | Biotechnology & Health Technologies 2 · Inception |
| 197 | Holy See | Europe | Loser | −39.8 | 4.4 | 44.2 | 6 | 12 | Biotechnology & Health Technologies 0 · Inception |
Settings of this run
- Required
- Health System CapabilityBiotechnology & Health TechnologiesPopulation HealthGovernment Effectiveness & Public AdministrationSocial InfrastructureRegulatory Governance & Strategic Controls
Readiness is the average of the mean and the minimum of the nation's scores on the capabilities the scenario requires, as a share of the top of the scale. The minimum holds it down: the weakest required capability limits the gain.
- Adaptive
- Fiscal Capacity & Public FinanceGovernment Effectiveness & Public AdministrationLifelong Learning & ReskillingLabour & Employment
- Gain exposure
- regional exposure (40%); low life expectancy at birth (ranked) (40%); adult obesity rate (ranked) (20%).
- Loss exposure
- Pension and long-term care liabilities in ageing populations: share of population aged 65 and over (ranked) (70%); regional exposure (30%). Gain and loss exposure are set nation by nation from indicators where one fits, and by region with named exceptions where none does.
- Likelihood
- 4 per cent over three years and 15 per cent over ten, as used in the opportunity index.